Back
Edgewise Therapeutics Vs. Amicus Therapeutics Industry Stock Comparison
Buy
82
EWTX
Edgewise Therapeutics
Last Price:
26.06
Seasonality Move:
12.51%
Sell
45
FOLD
Amicus Therapeutics
Last Price:
10.71
Seasonality Move:
-8.45%
Buy
82
Edgewise Therapeutics (EWTX)
is a Buy
Is Edgewise Therapeutics a Buy, Sell or Hold?
- The current Edgewise Therapeutics [EWTX] share price is $26.09. The Score for EWTX is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- EWTX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
45
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy, Sell or Hold?
- The current Amicus Therapeutics [FOLD] share price is $10.71. The Score for FOLD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- FOLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EWTX Stock Price Chart
What is Edgewise Therapeutics's stock price today?
-
The Edgewise Therapeutics share price today is $26.09
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EWTX is experiencing slight selling pressure.
FOLD Stock Price Chart
What is Amicus Therapeutics's stock price today?
-
The Amicus Therapeutics share price today is $10.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight selling pressure.
EWTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.17 | Buy |
| Relative Strength Index (14 RSI): | 65.34 | Buy |
| Chaikin Money Flow: | -231925 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.64 - 24.68) | Buy |
| Bollinger Bands (100): | (16.29 - 21.79) | Buy |
FOLD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 38.89 | Sell |
| Chaikin Money Flow: | -426216 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11 - 11.58) | Sell |
| Bollinger Bands (100): | (9.77 - 11.27) | Buy |
EWTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.9 | Buy |
| 20-day SMA: | 20.99 | Buy |
| 50-day SMA: | 19.47 | Buy |
| 200-day SMA: | 17.16 | Buy |
| 8-day EMA: | 24.98 | Buy |
| 20-day EMA: | 22.43 | Buy |
| 50-day EMA: | 20.37 | Buy |
| 200-day EMA: | 16.93 | Buy |
FOLD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.99 | Sell |
| 20-day SMA: | 11.25 | Sell |
| 50-day SMA: | 11.05 | Sell |
| 200-day SMA: | 11.43 | Sell |
| 8-day EMA: | 10.96 | Sell |
| 20-day EMA: | 11.13 | Sell |
| 50-day EMA: | 11.04 | Sell |
| 200-day EMA: | 11.14 | Sell |
Edgewise Therapeutics Earnings Growth & EWTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.05 per share, and a decrease next year of $0.35 per share.
Amicus Therapeutics Earnings Growth & FOLD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.06 per share, an increase this year of $0.51 per share, and an increase next year of $0.29 per share.
Edgewise Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amicus Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||